Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1988 1
1990 1
1996 2
1997 1
1998 1
1999 2
2000 1
2002 1
2004 4
2005 3
2006 5
2007 4
2008 8
2009 11
2010 15
2011 16
2012 23
2013 20
2014 26
2015 25
2016 17
2017 15
2018 21
2019 18
2020 24
2021 23
2022 26
2023 21
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

283 results

Results by year

Filters applied: . Clear all
Page 1
Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.
Wu YL, Dziadziuszko R, Ahn JS, Barlesi F, Nishio M, Lee DH, Lee JS, Zhong W, Horinouchi H, Mao W, Hochmair M, de Marinis F, Migliorino MR, Bondarenko I, Lu S, Wang Q, Ochi Lohmann T, Xu T, Cardona A, Ruf T, Noe J, Solomon BJ; ALINA Investigators. Wu YL, et al. N Engl J Med. 2024 Apr 11;390(14):1265-1276. doi: 10.1056/NEJMoa2310532. N Engl J Med. 2024. PMID: 38598794 Clinical Trial.
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer.
Im SA, Gennari A, Park YH, Kim JH, Jiang ZF, Gupta S, Fadjari TH, Tamura K, Mastura MY, Abesamis-Tiambeng MLT, Lim EH, Lin CH, Sookprasert A, Parinyanitikul N, Tseng LM, Lee SC, Caguioa P, Singh M, Naito Y, Hukom RA, Smruti BK, Wang SS, Kim SB, Lee KH, Ahn HK, Peters S, Kim TW, Yoshino T, Pentheroudakis G, Curigliano G, Harbeck N. Im SA, et al. Among authors: ahn hk. ESMO Open. 2023 Jun;8(3):101541. doi: 10.1016/j.esmoop.2023.101541. Epub 2023 May 11. ESMO Open. 2023. PMID: 37178669 Free PMC article.
TCF1+PD-1+ tumour-infiltrating lymphocytes predict a favorable response and prolonged survival after immune checkpoint inhibitor therapy for non-small-cell lung cancer.
Koh J, Kim S, Woo YD, Song SG, Yim J, Han B, Lim S, Ahn HK, Mun S, Kim JS, Keam B, Kim YA, Lee SH, Jeon YK, Chung DH. Koh J, et al. Among authors: ahn hk. Eur J Cancer. 2022 Oct;174:10-20. doi: 10.1016/j.ejca.2022.07.004. Epub 2022 Aug 12. Eur J Cancer. 2022. PMID: 35970031 Free article.
Immunological modes of pregnancy loss.
Kwak-Kim J, Park JC, Ahn HK, Kim JW, Gilman-Sachs A. Kwak-Kim J, et al. Among authors: ahn hk. Am J Reprod Immunol. 2010 Jun;63(6):611-23. doi: 10.1111/j.1600-0897.2010.00847.x. Epub 2010 Mar 29. Am J Reprod Immunol. 2010. PMID: 20367626 Review.
Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezolizumab, Docetaxel, and Trastuzumab Regimen for Patients With ERBB2-Positive Stage II/III Breast Cancer: The Neo-PATH Phase 2 Nonrandomized Clinical Trial.
Ahn HK, Sim SH, Suh KJ, Kim MH, Jeong JH, Kim JY, Lee DW, Ahn JH, Chae H, Lee KH, Kim JH, Lee KS, Sohn JH, Choi YL, Im SA, Jung KH, Park YH. Ahn HK, et al. JAMA Oncol. 2022 Sep 1;8(9):1271-1277. doi: 10.1001/jamaoncol.2022.2310. JAMA Oncol. 2022. PMID: 35797012 Free PMC article. Clinical Trial.
283 results